Ranbaxy Laboratories on Tuesday announced a business alliance with Orchid Chemicals and Pharmaceuticals across multiple geographies and therapies, for finished dosage formulations and bulk drugs. Dr C B Rao, Orchid’s deputy managing director, spoke to PB Jayakumar on the partnership and the recent share purchases made by Ranbaxy through Solrex.Which are the areas of co-operation […]
European health care firm Fresenius Kabi, which acquired 73.3 per cent control of Dabur Pharma last week, today announced a public offer to purchase further 20 per cent stake in the domestic drug firm at a price of Rs 76.50 per equity share in cash.
The deal for control of the company cost the European firm […]
Biocon board meet on Apr 22 for bonus issue
addthis_url = ‘http%3A%2F%2Fbirlaa.com%2F2008%2F04%2F21%2Fbiocon-bonus-issue%2F’;
addthis_title = ‘Biocon+Bonus+Issue’;
addthis_pub = ”;
Orchid Chemicals’ shares plunged 12.5% or Rs 40 to Rs 279 on Thursday from Wednesday’s close of Rs 319 at BSE. The company’s stocks had hit a 52-week high of Rs 343 during the day on speculation about Ranbaxy making an open offer for Orchid today. But with no such move forthcoming there was disappointment […]
Foreign fund Morgan Stanley on Tuesday picked up 0.50 per cent stake in Orchid Chemicals for Rs 8.90 crore in open market transactions.
Morgan Stanley and Co International has acquired 3.30 lakh shares of Orchid Chemicals at a price of Rs 269.83 each in a bulk deal at the BSE, information available on the exchange showed.
The […]
n spite of an orchid’s legendary inability to bloom in most habitats, K Ragavendra Rao has ensured Orchid Chemicals and Pharmaceuticals Ltd is blooming globally. On April 10, days after Rao’s Orchid was in the news as a hostile takeover target, the company announced its entry into the world’s toughest pharma market — Japan.
The wholly-owned […]
The promoters of mid-sized pharma company Strides Arcolab have increased their holding in the company by a little over 4% in recent weeks. The Bangalore-headquartered Strides Arcolab, a significant player in soft gelatin capsules and steriles, has been under the spotlight in the wake of an apparent attempt by a Ranbaxy linked company to buy […]
Deputy MD says Solrex is linked to Ranbaxy, but stake buy isn’t a takeover attempt.
Orchid Chemicals & Pharmaceuticals said today that major stakeholder Solrex Pharmaceuticals is linked to Ranbaxy Laboratories, but it did not expect a takeover attempt.
Privately held Solrex has acquired an 11.4 per cent stake in Chennai-based Orchid, a bulk drugs and formulations […]
